BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 23123334)

  • 1. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
    Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
    J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterometallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behaviour and anticancer activity.
    Nieto D; González-Vadillo AM; Bruña S; Pastor CJ; Ríos-Luci C; León LG; Padrón JM; Navarro-Ranninger C; Cuadrado I
    Dalton Trans; 2012 Jan; 41(2):432-41. PubMed ID: 22025199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
    Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
    Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and cytotoxic activity of substituted benzyl iminoether Pt(II) complexes of the type cis- and trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-R}2] (R=Me, OMe, F). X-ray structure of trans-[PtCl2{E-N(H)=C(OMe)CH2-C6H4-p-F}2].
    Mazzega Sbovata S; Bettio F; Marzano C; Tassan A; Mozzon M; Bertani R; Benetollo F; Michelin RA
    J Inorg Biochem; 2008 Apr; 102(4):882-91. PubMed ID: 18267343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flexible kappa4-PNN'O-tetradentate ligands: synthesis, complexation and structural studies.
    Durran SE; Elsegood MR; Hammond SR; Smith MB
    Dalton Trans; 2010 Aug; 39(30):7136-46. PubMed ID: 20577684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl].
    Guo SX; Mason DN; Turland SA; Lawrenz ET; Kelly LC; Fallon GD; Gatehouse BM; Bond AM; Deacon GB; Battle AR; Hambley TW; Rainone S; Webster LK; Cullinane C
    J Inorg Biochem; 2012 Oct; 115():226-39. PubMed ID: 22921430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and mechanistic study of the Pt(II) versus Pt(IV) effect in the platinum-mediated nitrile-hydroxylamine coupling.
    Luzyanin KV; Kukushkin VY; Ryabov AD; Haukka M; Pombeiro AJ
    Inorg Chem; 2005 Apr; 44(8):2944-53. PubMed ID: 15819582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
    J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium(II) and ruthenium(IV) complexes containing kappa1-P-, kappa2-P,O-, and kappa3-P,N,O-iminophosphorane-phosphine ligands Ph2PCH2P[=NP(=O)(OR)2]Ph2 (R = Et, Ph): synthesis, reactivity, theoretical studies, and catalytic activity in transfer hydrogenation of cyclohexanone.
    Cadierno V; Crochet P; Díez J; García-Alvarez J; García-Garrido SE; Gimeno J; García-Granda S; Rodríguez MA
    Inorg Chem; 2003 May; 42(10):3293-307. PubMed ID: 12739971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven-membered cycloplatinated complexes as a new family of anticancer agents. X-ray characterization and preliminary biological studies.
    Cortés R; Crespo M; Davin L; Martín R; Quirante J; Ruiz D; Messeguer R; Calvis C; Baldomà L; Badia J; Font-Bardía M; Calvet T; Cascante M
    Eur J Med Chem; 2012 Aug; 54():557-66. PubMed ID: 22770537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the structures and reactivity of cyclometallated platinum compounds of N-benzylidenebenzylamines and cycloplatination of a primary amine.
    Capapé A; Crespo M; Granell J; Font-Bardía M; Solans X
    Dalton Trans; 2007 May; (20):2030-9. PubMed ID: 17502936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cis-[(NHC)
    Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
    Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pt(II) complexes with (N,N') or (C,N,E)(-) (E=N,S) ligands: cytotoxic studies, effect on DNA tertiary structure and structure-activity relationships.
    Albert J; Bosque R; Crespo M; Granell J; López C; Cortés R; Gonzalez A; Quirante J; Calvis C; Messeguer R; Baldomà L; Badia J; Cascante M
    Bioorg Med Chem; 2013 Jul; 21(14):4210-7. PubMed ID: 23735827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel platinum(II) complexes of 3-(aminomethyl)naphthoquinone Mannich bases: synthesis, crystal structure and cytotoxic activities.
    Neves AP; da Silva GB; Vargas MD; Pinheiro CB; Visentin Ldo C; Filho JD; Araújo AJ; Costa-Lotufo LV; Pessoa C; de Moraes MO
    Dalton Trans; 2010 Nov; 39(42):10203-16. PubMed ID: 20871881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
    Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
    Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
    Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum(II)-mediated coupling reactions of acetonitrile with the exocyclic nitrogen of 9-methyladenine and 1-methylcytosine. Synthesis, NMR characterization, and X-ray structures of new azametallacycle complexes.
    Longato B; Montagner D; Bandoli G; Zangrando E
    Inorg Chem; 2006 Feb; 45(4):1805-14. PubMed ID: 16471997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.